FI52089C - Sätt att framställa terapeutiskt verksamma cis-benzo/c//1,6/naftyridin derivat. - Google Patents
Sätt att framställa terapeutiskt verksamma cis-benzo/c//1,6/naftyridin derivat.Info
- Publication number
- FI52089C FI52089C FI129371A FI129371A FI52089C FI 52089 C FI52089 C FI 52089C FI 129371 A FI129371 A FI 129371A FI 129371 A FI129371 A FI 129371A FI 52089 C FI52089 C FI 52089C
- Authority
- FI
- Finland
- Prior art keywords
- benzo
- preparation
- therapeutically active
- naphthyridine derivatives
- active cis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH708970A CH527822A (de) | 1970-05-13 | 1970-05-13 | Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate |
| CH708670A CH527196A (de) | 1970-05-13 | 1970-05-13 | Verfahren zur Herstellung neuer Benzonaphthyridinderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI52089B FI52089B (sv) | 1977-02-28 |
| FI52089C true FI52089C (sv) | 1977-06-10 |
Family
ID=25700728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI129371A FI52089C (sv) | 1970-05-13 | 1971-05-11 | Sätt att framställa terapeutiskt verksamma cis-benzo/c//1,6/naftyridin derivat. |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5432799B1 (sv) |
| AT (1) | AT326674B (sv) |
| CA (1) | CA970377A (sv) |
| CS (2) | CS167202B2 (sv) |
| DE (1) | DE2123328A1 (sv) |
| DK (1) | DK134488B (sv) |
| ES (1) | ES391026A1 (sv) |
| FI (1) | FI52089C (sv) |
| FR (1) | FR2100649B1 (sv) |
| GB (1) | GB1361441A (sv) |
| NL (1) | NL7106502A (sv) |
| PL (1) | PL76913B1 (sv) |
| SE (1) | SE387640B (sv) |
| SU (1) | SU423296A3 (sv) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3899494A (en) * | 1970-05-13 | 1975-08-12 | Sandoz Ltd | Substituted 6-phenyl benzo-naphthyridines |
| NL7314396A (sv) * | 1972-10-26 | 1974-05-01 | ||
| BE880455A (fr) * | 1979-01-22 | 1980-06-06 | Sandoz Sa | Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine |
| DK0988302T3 (da) | 1997-06-03 | 2003-06-02 | Altana Pharma Ag | Benzonaphthyridiner |
| DE60043318D1 (de) | 1999-08-21 | 2010-01-14 | Nycomed Gmbh | Synergistische kombination von pumafentrine und salmeterol |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| KR20050115331A (ko) | 2003-04-01 | 2005-12-07 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 불임증 포스포디에스터라제의 억제제 |
| BRPI0510951A (pt) * | 2004-05-12 | 2007-11-20 | Pfizer Prod Inc | derivados de piperidina como antagonistas de nk1 e nk3 |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US9580471B2 (en) | 2011-03-01 | 2017-02-28 | Synergy Pharmaceuticals, Inc. | Process of preparing guanylate cyclase C agonists |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
-
1971
- 1971-05-10 GB GB1398471A patent/GB1361441A/en not_active Expired
- 1971-05-11 DK DK225771A patent/DK134488B/da unknown
- 1971-05-11 CS CS920771A patent/CS167202B2/cs unknown
- 1971-05-11 SU SU1656559A patent/SU423296A3/ru active
- 1971-05-11 DE DE19712123328 patent/DE2123328A1/de not_active Ceased
- 1971-05-11 ES ES391026A patent/ES391026A1/es not_active Expired
- 1971-05-11 PL PL14807271A patent/PL76913B1/pl unknown
- 1971-05-11 FI FI129371A patent/FI52089C/sv active
- 1971-05-11 CS CS341671A patent/CS162753B2/cs unknown
- 1971-05-12 NL NL7106502A patent/NL7106502A/xx not_active Application Discontinuation
- 1971-05-12 CA CA112,767A patent/CA970377A/en not_active Expired
- 1971-05-12 SE SE613471A patent/SE387640B/sv unknown
- 1971-05-12 FR FR7117124A patent/FR2100649B1/fr not_active Expired
- 1971-05-12 AT AT412471A patent/AT326674B/de not_active IP Right Cessation
- 1971-05-12 JP JP3189471A patent/JPS5432799B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2100649A1 (sv) | 1972-03-24 |
| ES391026A1 (es) | 1974-04-01 |
| NL7106502A (sv) | 1971-11-16 |
| DK134488C (sv) | 1977-05-16 |
| SU423296A3 (ru) | 1974-04-05 |
| CS162753B2 (sv) | 1975-07-15 |
| GB1361441A (en) | 1974-07-24 |
| SE387640B (sv) | 1976-09-13 |
| PL76913B1 (en) | 1975-02-28 |
| JPS5432799B1 (sv) | 1979-10-16 |
| FI52089B (sv) | 1977-02-28 |
| FR2100649B1 (sv) | 1974-08-30 |
| DE2123328A1 (de) | 1971-12-02 |
| ATA412471A (de) | 1975-03-15 |
| AT326674B (de) | 1975-12-29 |
| CA970377A (en) | 1975-07-01 |
| DK134488B (da) | 1976-11-15 |
| CS167202B2 (sv) | 1976-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI52089C (sv) | Sätt att framställa terapeutiskt verksamma cis-benzo/c//1,6/naftyridin derivat. | |
| NO140301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner | |
| SE400280B (sv) | 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
| FI49300C (sv) | Förfarande för framställning av terapeutiskt aktiva 1,4-dihydropyridin derivater. | |
| FI49515C (sv) | Förfarande för framställning av farmakologiskt aktiva 11-ställning sub stituerade 5,11-dihydro-6H-pyrido/2,3-b//1,4/benzodiazepin-6-oner. | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| FI49503C (sv) | Analogiförfarande för framställning av 1,2,3,4-tetrahydro-4-fenyl-isok inolinderivat. | |
| FI48588C (sv) | Analogiförfarande för framställning av terapeutiskt verksamma 3,4-dihy droisokinolinderivat. | |
| NO740327L (no) | Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner. | |
| NO741744L (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin. | |
| FI49827C (sv) | Förfarande för framställning av substituerade 3-hydroximetyl-isokinoli ner med terapeutisk verkan. | |
| FI49504C (sv) | Förfarande för framställning av farmakologiskt versamma bensocyklohept aisokinolinderivat. | |
| PH12247A (en) | Pharmaceutically active compounds | |
| NO136574C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO740614L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser. | |
| SE400768B (sv) | Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon | |
| NO741752L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner. | |
| FI49718C (sv) | Förfarande för framställning av terapeutiskt verksamma 2-halogenmetyl- 3-karbonsyraamidokinoxalin-di-N-oxider-(1,4) | |
| FI51349C (sv) | Förfarande för framställning av terapeutiskt verksamma N-substituerade 6,7-bensomorfaner. | |
| NO741044L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner. | |
| FI49514C (sv) | Förfarande för framställning av farmaceutiskt aktiva i 11-ställning su bstituerade 5,11-dihydro-6H-pyrido(2,3-b)(1,4) benzodiazepin-6-oner. | |
| FI50630C (sv) | Förfarande för framställning av farmakologiskst verksamma 2,3,4,4a-tet rahydro-10H-1,2-oxazino (3,2-b) (1,3) benzoxazin-10-oner. | |
| FI50629C (sv) | Förfarande för framställning av nya terapeutiskt aktiva 2,3-dihydro-1H -tieno-bentsotiepino(4,5-c)pyrrolföreningar. | |
| FI47357C (sv) | Förfarande för framställning av terapeutiskt verkande derivat av 4'-de metyl-epipodofyllotoxin-beta-D-glukosid. | |
| FI50875C (sv) | Förfarande för framställning av terapeutiskt aktiva dihydro-2-aminoiso kinoliner. |